Apalutamide with Gepirone Interaction Details


Brand Names Associated with Apalutamide

  • Apalutamide
  • Erleada®

Medical Content Editor
Last updated Mar 04, 2024


Curious for more information about this interaction?

Ask our pharmacists directly!

Reach out to us

Interaction Effect

Reduced gepirone exposure


Interaction Summary

Avoid concomitant use of gepirone with a strong CYP3A4 inducer. Concomitant use of gepirone with rifAMPin (a strong CYP3A4 inducer) among 24 subjects, reduced the exposure of gepirone by 20- to 29-fold[1].


Severity

Major


Onset

Unspecified


Evidence

Probable


How To Manage Interaction

Avoid concomitant use of gepirone with a strong CYP3A4 inducer. Concomitant use of gepirone with a strong CYP3A4 inducer may reduce the exposure of gepirone by 20- to 29-fold[1].


Mechanism Of Interaction

Induction of CYP3A4-mediated metabolism of gepirone


Literature Reports

A) In drug interaction studies conducted among 24 subjects, coadministration of gepirone (20 mg daily for two days followed by 40 mg daily) with rifAMPin 600 mg daily (a strong CYP3A4 inducer) decreased the Cmax and AUC(0 to 24) of gepirone by 20 times and 29 times, respectively. The Cmax and AUC (0 to 24) of 3-OH gepirone (a major metabolite of gepirone) were decreased 2.5 times and 3 times, respectively [1].

References

    1 ) Product Information: EXXUA extended-release oral tablets, gepirone extended-release oral tablets. Mission Pharmaceutical Company (per FDA), San Antonio, TX, 2023.

Apalutamide Overview

  • Apalutamide is used to treat certain types of prostate cancer (cancer in men that begins in the prostate [a male reproductive gland]) and has spread to other parts of the body or that has not spread to other parts of the body but has not been helped by other medical treatments. Apalutamide is in a class of medications called androgen receptor inhibitors. It works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of cancer cells.

See More information Regarding Apalutamide

Return To Our Drug Interaction Homepage


Feedback, Question Or Comment About This Information?

Ask , our medical editor, directly! He's always more than happy to assist.


Definitions

Severity Categories

Contraindicated

These drugs, generally, should not be used together simultaneously due to the high risk of severe adverse effects. Combining these medications can lead to dangerous health outcomes and should be strictly avoided unless otherwise instructed by your provider.


Major

This interaction could result in very serious and potentially life-threatening consequences. If you are taking this drug combination, it is very important to be under close medical supervision to minimize severe side effects and ensure your safety. It may be necessary to change a medication or dosage to prevent harm.


Moderate

This interaction has the potential to worsen your medical condition or alter the effectiveness of your treatment. It's important that you are monitored closely and you potentially may need to make adjustments in your treatment plan or drug dosage to maintain optimal health.


Minor

While this interaction is unlikely to cause significant problems, it could intensify side effects or reduce the effectiveness of one or both medications. Monitoring for changes in symptoms and your condition is recommended, and adjustments may be made if needed to manage any increased or more pronounced side effects.


Onset

Rapid: Onset of drug interaction typically occurs within 24 hours of co-administration.

Delayed: Onset of drug interaction typically occurs more than 24 hours after co-administration.


Evidence

Level of documentation of the interaction.

Established: The interaction is documented and substantiated in peer-reviewed medical literature.

Theoretical: This interaction is not fully supported by current medical evidence or well-documented sources, but it is based on known drug mechanisms, drug effects, and other relevant information.


How To Manage The Interaction

Provides a detailed discussion on how patients and clinicians can approach the identified drug interaction as well as offers guidance on what to expect and strategies to potentially mitigate the effects of the interaction. This may include recommendations on adjusting medication dosages, altering the timing of drug administration, or closely monitoring for specific symptoms.

It's important to note that all medical situations are unique, and management approaches should be tailored to individual circumstances. Patients should always consult their healthcare provider for personalized advice and guidance on managing drug interactions effectively.


Mechanism Of Interaction

The theorized or clinically determined reason (i.e., mechanism) why the drug-drug interaction occurs.


Disclaimer: The information provided on this page is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional regarding your specific circumstances and medical conditions.

Where Does Our Information Come From?

Information for our drug interactions is compiled from several drug compendia, including:

The prescribing information for each drug, as published on DailyMED, is also used. 

Individual drug-drug interaction detail pages contain references specific to that interaction. You can click on the reference number within brackets '[]' to see what reference was utilized.

The information posted is fact-checked by HelloPharmacist clinicians and reviewed quarterly.